Global Pneumococcal Conjugate Vaccine (PCV) Market Research Report 2025(Status and Outlook)

March 2025 | 163 pages | ID: G5F1B4E9524CEN
Bosson Research

Abstracts

Report Overview

Pneumococcal Conjugate Vaccine (PCV) is a type of vaccine that helps protect against infections caused by the bacterium Streptococcus pneumoniae, which can lead to serious illnesses such as pneumonia, meningitis, and sepsis. PCV works by stimulating the immune system to produce antibodies against specific strains of the bacteria, reducing the likelihood of infection and its associated complications. This vaccine is typically administered to infants and young children, as they are more susceptible to severe pneumococcal infections. In recent years, there has been a growing emphasis on the importance of vaccination in preventing infectious diseases, leading to an increased demand for PCV in both developed and developing countries.

The market for Pneumococcal Conjugate Vaccine (PCV) is experiencing significant growth driven by several key factors. One of the primary market drivers is the rising awareness among healthcare providers and the general population about the importance of vaccination in preventing pneumococcal infections. Governments and healthcare organizations worldwide are increasingly promoting immunization programs that include PCV, further boosting its demand. Additionally, the growing prevalence of pneumococcal diseases, especially in vulnerable populations such as infants, the elderly, and individuals with compromised immune systems, is driving the market for PCV. Moreover, advancements in vaccine technology and the introduction of new and improved PCV formulations are also contributing to the market growth.

This report provides a deep insight into the global Pneumococcal Conjugate Vaccine (PCV) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pneumococcal Conjugate Vaccine (PCV) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pneumococcal Conjugate Vaccine (PCV) market in any manner.

Global Pneumococcal Conjugate Vaccine (PCV) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Pfizer

GSK

Sanofi

Merck

Walvax Biotechnology

Royal (Wuxi) Bio-Pharmaceutical

Zhifei Biologic

Serum Institute of India

Market Segmentation (by Type)

23-valent Vaccine

10-valent Vaccine

7-valent Vaccine

13-valent Vaccine

Market Segmentation (by Application)

Child

Adult

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Pneumococcal Conjugate Vaccine (PCV) Market
• Overview of the regional outlook of the Pneumococcal Conjugate Vaccine (PCV) Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumococcal Conjugate Vaccine (PCV) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Pneumococcal Conjugate Vaccine (PCV)
1.2 Key Market Segments
  1.2.1 Pneumococcal Conjugate Vaccine (PCV) Segment by Type
  1.2.2 Pneumococcal Conjugate Vaccine (PCV) Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Pneumococcal Conjugate Vaccine (PCV) Product Life Cycle
3.3 Global Pneumococcal Conjugate Vaccine (PCV) Sales by Manufacturers (2020-2025)
3.4 Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Manufacturers (2020-2025)
3.5 Pneumococcal Conjugate Vaccine (PCV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pneumococcal Conjugate Vaccine (PCV) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Pneumococcal Conjugate Vaccine (PCV) Manufacturing Sites, Area Served, Product Type
3.8 Pneumococcal Conjugate Vaccine (PCV) Market Competitive Situation and Trends
  3.8.1 Pneumococcal Conjugate Vaccine (PCV) Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Pneumococcal Conjugate Vaccine (PCV) Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) INDUSTRY CHAIN ANALYSIS

4.1 Pneumococcal Conjugate Vaccine (PCV) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Pneumococcal Conjugate Vaccine (PCV) Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Pneumococcal Conjugate Vaccine (PCV) Market
5.7 ESG Ratings of Leading Companies

6 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Type (2020-2025)
6.3 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2020-2025)
6.4 Global Pneumococcal Conjugate Vaccine (PCV) Price by Type (2020-2025)

7 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Sales by Application (2020-2025)
7.3 Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) by Application (2020-2025)
7.4 Global Pneumococcal Conjugate Vaccine (PCV) Sales Growth Rate by Application (2020-2025)

8 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET SALES BY REGION

8.1 Global Pneumococcal Conjugate Vaccine (PCV) Sales by Region
  8.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Sales by Region
  8.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region
8.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Region
  8.2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Region
  8.2.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region
8.3 North America
  8.3.1 North America Pneumococcal Conjugate Vaccine (PCV) Sales by Country
  8.3.2 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Pneumococcal Conjugate Vaccine (PCV) Sales by Country
  8.4.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales by Region
  8.5.2 Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Pneumococcal Conjugate Vaccine (PCV) Sales by Country
  8.6.2 South America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Sales by Region
  8.7.2 Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET PRODUCTION BY REGION

9.1 Global Production of Pneumococcal Conjugate Vaccine (PCV) by Region(2020-2025)
9.2 Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Region (2020-2025)
9.3 Global Pneumococcal Conjugate Vaccine (PCV) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pneumococcal Conjugate Vaccine (PCV) Production
  9.4.1 North America Pneumococcal Conjugate Vaccine (PCV) Production Growth Rate (2020-2025)
  9.4.2 North America Pneumococcal Conjugate Vaccine (PCV) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pneumococcal Conjugate Vaccine (PCV) Production
  9.5.1 Europe Pneumococcal Conjugate Vaccine (PCV) Production Growth Rate (2020-2025)
  9.5.2 Europe Pneumococcal Conjugate Vaccine (PCV) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pneumococcal Conjugate Vaccine (PCV) Production (2020-2025)
  9.6.1 Japan Pneumococcal Conjugate Vaccine (PCV) Production Growth Rate (2020-2025)
  9.6.2 Japan Pneumococcal Conjugate Vaccine (PCV) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pneumococcal Conjugate Vaccine (PCV) Production (2020-2025)
  9.7.1 China Pneumococcal Conjugate Vaccine (PCV) Production Growth Rate (2020-2025)
  9.7.2 China Pneumococcal Conjugate Vaccine (PCV) Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Pfizer
  10.1.1 Pfizer Basic Information
  10.1.2 Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Overview
  10.1.3 Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
  10.1.4 Pfizer Business Overview
  10.1.5 Pfizer SWOT Analysis
  10.1.6 Pfizer Recent Developments
10.2 GSK
  10.2.1 GSK Basic Information
  10.2.2 GSK Pneumococcal Conjugate Vaccine (PCV) Product Overview
  10.2.3 GSK Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
  10.2.4 GSK Business Overview
  10.2.5 GSK SWOT Analysis
  10.2.6 GSK Recent Developments
10.3 Sanofi
  10.3.1 Sanofi Basic Information
  10.3.2 Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Overview
  10.3.3 Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
  10.3.4 Sanofi Business Overview
  10.3.5 Sanofi SWOT Analysis
  10.3.6 Sanofi Recent Developments
10.4 Merck
  10.4.1 Merck Basic Information
  10.4.2 Merck Pneumococcal Conjugate Vaccine (PCV) Product Overview
  10.4.3 Merck Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
  10.4.4 Merck Business Overview
  10.4.5 Merck Recent Developments
10.5 Walvax Biotechnology
  10.5.1 Walvax Biotechnology Basic Information
  10.5.2 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Overview
  10.5.3 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
  10.5.4 Walvax Biotechnology Business Overview
  10.5.5 Walvax Biotechnology Recent Developments
10.6 Royal (Wuxi) Bio-Pharmaceutical
  10.6.1 Royal (Wuxi) Bio-Pharmaceutical Basic Information
  10.6.2 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Overview
  10.6.3 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
  10.6.4 Royal (Wuxi) Bio-Pharmaceutical Business Overview
  10.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
10.7 Zhifei Biologic
  10.7.1 Zhifei Biologic Basic Information
  10.7.2 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Overview
  10.7.3 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
  10.7.4 Zhifei Biologic Business Overview
  10.7.5 Zhifei Biologic Recent Developments
10.8 Serum Institute of India
  10.8.1 Serum Institute of India Basic Information
  10.8.2 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Overview
  10.8.3 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
  10.8.4 Serum Institute of India Business Overview
  10.8.5 Serum Institute of India Recent Developments

11 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET FORECAST BY REGION

11.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast
11.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country
  11.2.3 Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Region
  11.2.4 South America Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Pneumococcal Conjugate Vaccine (PCV) by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Pneumococcal Conjugate Vaccine (PCV) by Type (2026-2033)
  12.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Pneumococcal Conjugate Vaccine (PCV) by Type (2026-2033)
12.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Forecast by Application (2026-2033)
  12.2.1 Global Pneumococcal Conjugate Vaccine (PCV) Sales (K MT) Forecast by Application
  12.2.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pneumococcal Conjugate Vaccine (PCV) Market Size Comparison by Region (M USD)
Table 5. Global Pneumococcal Conjugate Vaccine (PCV) Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Pneumococcal Conjugate Vaccine (PCV) Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Conjugate Vaccine (PCV) as of 2024)
Table 10. Global Market Pneumococcal Conjugate Vaccine (PCV) Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Pneumococcal Conjugate Vaccine (PCV) Manufacturing Sites and Area Served
Table 12. Manufacturers Pneumococcal Conjugate Vaccine (PCV) Product Type
Table 13. Global Pneumococcal Conjugate Vaccine (PCV) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Pneumococcal Conjugate Vaccine (PCV) Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Pneumococcal Conjugate Vaccine (PCV) Sales by Type (K MT)
Table 25. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (M USD)
Table 26. Global Pneumococcal Conjugate Vaccine (PCV) Sales (K MT) by Type (2020-2025)
Table 27. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Type (2020-2025)
Table 28. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) by Type (2020-2025)
Table 29. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Share by Type (2020-2025)
Table 30. Global Pneumococcal Conjugate Vaccine (PCV) Price (USD/MT) by Type (2020-2025)
Table 31. Global Pneumococcal Conjugate Vaccine (PCV) Sales (K MT) by Application
Table 32. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Application
Table 33. Global Pneumococcal Conjugate Vaccine (PCV) Sales by Application (2020-2025) & (K MT)
Table 34. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Application (2020-2025)
Table 35. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2020-2025) & (M USD)
Table 36. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2020-2025)
Table 37. Global Pneumococcal Conjugate Vaccine (PCV) Sales Growth Rate by Application (2020-2025)
Table 38. Global Pneumococcal Conjugate Vaccine (PCV) Sales by Region (2020-2025) & (K MT)
Table 39. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region (2020-2025)
Table 40. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2020-2025) & (M USD)
Table 41. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region (2020-2025)
Table 42. North America Pneumococcal Conjugate Vaccine (PCV) Sales by Country (2020-2025) & (K MT)
Table 43. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Pneumococcal Conjugate Vaccine (PCV) Sales by Country (2020-2025) & (K MT)
Table 45. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2020-2025) & (M USD)
Table 48. South America Pneumococcal Conjugate Vaccine (PCV) Sales by Country (2020-2025) & (K MT)
Table 49. South America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2020-2025) & (M USD)
Table 52. Global Pneumococcal Conjugate Vaccine (PCV) Production (K MT) by Region(2020-2025)
Table 53. Global Pneumococcal Conjugate Vaccine (PCV) Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Region (2020-2025)
Table 55. Global Pneumococcal Conjugate Vaccine (PCV) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Pneumococcal Conjugate Vaccine (PCV) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Pneumococcal Conjugate Vaccine (PCV) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Pneumococcal Conjugate Vaccine (PCV) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Pneumococcal Conjugate Vaccine (PCV) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Pfizer Basic Information
Table 61. Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 62. Pfizer Pneumococcal Conjugate Vaccine (PCV) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Pfizer Business Overview
Table 64. Pfizer SWOT Analysis
Table 65. Pfizer Recent Developments
Table 66. GSK Basic Information
Table 67. GSK Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 68. GSK Pneumococcal Conjugate Vaccine (PCV) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. GSK Business Overview
Table 70. GSK SWOT Analysis
Table 71. GSK Recent Developments
Table 72. Sanofi Basic Information
Table 73. Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 74. Sanofi Pneumococcal Conjugate Vaccine (PCV) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Sanofi Business Overview
Table 76. Sanofi SWOT Analysis
Table 77. Sanofi Recent Developments
Table 78. Merck Basic Information
Table 79. Merck Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 80. Merck Pneumococcal Conjugate Vaccine (PCV) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Merck Business Overview
Table 82. Merck Recent Developments
Table 83. Walvax Biotechnology Basic Information
Table 84. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 85. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Walvax Biotechnology Business Overview
Table 87. Walvax Biotechnology Recent Developments
Table 88. Royal (Wuxi) Bio-Pharmaceutical Basic Information
Table 89. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 90. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Royal (Wuxi) Bio-Pharmaceutical Business Overview
Table 92. Royal (Wuxi) Bio-Pharmaceutical Recent Developments
Table 93. Zhifei Biologic Basic Information
Table 94. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 95. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Zhifei Biologic Business Overview
Table 97. Zhifei Biologic Recent Developments
Table 98. Serum Institute of India Basic Information
Table 99. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 100. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Serum Institute of India Business Overview
Table 102. Serum Institute of India Recent Developments
Table 103. Global Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Region (2026-2033) & (K MT)
Table 104. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Region (2026-2033) & (M USD)
Table 105. North America Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Country (2026-2033) & (K MT)
Table 106. North America Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country (2026-2033) & (M USD)
Table 107. Europe Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Country (2026-2033) & (K MT)
Table 108. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country (2026-2033) & (M USD)
Table 109. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Region (2026-2033) & (K MT)
Table 110. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Region (2026-2033) & (M USD)
Table 111. South America Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Country (2026-2033) & (K MT)
Table 112. South America Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country (2026-2033) & (M USD)
Table 113. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Country (2026-2033) & (Units)
Table 114. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country (2026-2033) & (M USD)
Table 115. Global Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Type (2026-2033) & (K MT)
Table 116. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Type (2026-2033) & (M USD)
Table 117. Global Pneumococcal Conjugate Vaccine (PCV) Price Forecast by Type (2026-2033) & (USD/MT)
Table 118. Global Pneumococcal Conjugate Vaccine (PCV) Sales (K MT) Forecast by Application (2026-2033)
Table 119. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Pneumococcal Conjugate Vaccine (PCV)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD), 2024-2033
Figure 5. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) (2020-2033)
Figure 6. Global Pneumococcal Conjugate Vaccine (PCV) Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pneumococcal Conjugate Vaccine (PCV) Product Life Cycle
Figure 13. Pneumococcal Conjugate Vaccine (PCV) Sales Share by Manufacturers in 2024
Figure 14. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Share by Manufacturers in 2024
Figure 15. Pneumococcal Conjugate Vaccine (PCV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Pneumococcal Conjugate Vaccine (PCV) Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pneumococcal Conjugate Vaccine (PCV) Revenue in 2024
Figure 18. Industry Chain Map of Pneumococcal Conjugate Vaccine (PCV)
Figure 19. Global Pneumococcal Conjugate Vaccine (PCV) Market PEST Analysis
Figure 20. Global Pneumococcal Conjugate Vaccine (PCV) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Type
Figure 27. Sales Market Share of Pneumococcal Conjugate Vaccine (PCV) by Type (2020-2025)
Figure 28. Sales Market Share of Pneumococcal Conjugate Vaccine (PCV) by Type in 2024
Figure 29. Market Size Share of Pneumococcal Conjugate Vaccine (PCV) by Type (2020-2025)
Figure 30. Market Size Share of Pneumococcal Conjugate Vaccine (PCV) by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application
Figure 33. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Application (2020-2025)
Figure 34. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Application in 2024
Figure 35. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2020-2025)
Figure 36. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application in 2024
Figure 37. Global Pneumococcal Conjugate Vaccine (PCV) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region (2020-2025)
Figure 39. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region (2020-2025)
Figure 40. North America Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Country in 2024
Figure 43. North America Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Country in 2024
Figure 45. U.S. Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pneumococcal Conjugate Vaccine (PCV) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pneumococcal Conjugate Vaccine (PCV) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pneumococcal Conjugate Vaccine (PCV) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Country in 2024
Figure 53. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Country in 2024
Figure 55. Germany Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region in 2024
Figure 68. China Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (K MT)
Figure 79. South America Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Country in 2024
Figure 80. South America Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (M USD)
Figure 81. South America Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Country in 2024
Figure 82. Brazil Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pneumococcal Conjugate Vaccine (PCV) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pneumococcal Conjugate Vaccine (PCV) Production Market Share by Region (2020-2025)
Figure 103. North America Pneumococcal Conjugate Vaccine (PCV) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pneumococcal Conjugate Vaccine (PCV) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pneumococcal Conjugate Vaccine (PCV) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pneumococcal Conjugate Vaccine (PCV) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Pneumococcal Conjugate Vaccine (PCV) Market Share Forecast by Type (2026-2033)
Figure 111. Global Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Application (2026-2033)
Figure 112. Global Pneumococcal Conjugate Vaccine (PCV) Market Share Forecast by Application (2026-2033)